Lupus & antiphospholipid syndrome

Preclinical ocular changes in systemic lupus erythematosus patients by optical coherence tomography

Rheumatology (Oxford)Published Cross-sectional study

Authors' conclusion

SD-OCT and OCTA can detect preclinical structural and microcirculatory changes in SLE patients.

Study context

Population
SLE patients and healthy volunteers assessed by spectral-domain optical coherence tomography (SD-OCT) and OCT angiography
Participants
78 vs 80
Exposure
SLE patients vs healthy volunteers
  • SLEn = 78
  • Healthy volunteersn = 80reference
Outcome
Structural (macular and RNFL thickness, SD-OCT) and perifoveal vascular (vessel density, vascular perfusion, FAZ) parameters (OCTA)
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

SD-OCT structural and OCTA perifoveal vascular parameters
  • Structural parameters by SD-OCT and perifoveal vascular parameters by OCT angiography (OCTA) decreased in SLE patients vs controls

Observational data: associations, not effects.

Further findings

OCTA parameters and macular thickness by disease duration

OCTA parameters (vessel density (VD), vascular perfusion (VP), foveal avascular zone (FAZ) circularity) and macular thickness decreased with longer disease duration (>10 years)

Retinal nerve fibre layer (RNFL) thickness by aPL

aPL presence associated with decreased RNFL thickness, mainly in inferior quadrants

RNFL thickness and OCTA flow in APS

Patients developing APS showed decreased RNFL thickness and OCTA flow changes

SD-OCT and OCTA vs disease activity

Not associated with disease activity

Foveal structural parameters by damage score

Lower in patients with higher damage score

Original publication

Preclinical ocular changes in systemic lupus erythematosus patients by optical coherence tomography. Rheumatology (Oxford). Published 4 November 2022. doi:10.1093/rheumatology/keac626

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.